1887

Abstract

We aimed to investigate the presence of three recently identified point mutations (A2115G, G2141A and A2144T) of the 23 S rRNA gene and compare them with the three most frequently encountered point mutations (A2142G, A2142C and A2143G) in strains in Turkey.

A total of 63 patients (mean 47.08±12.27) were included. The E-test method (for clarithromycin) was used for the clarithromycin antimicrobial susceptibility test of isolated strains. Real-time PCR was used to detect the point mutations.

A total of 24 out of 63 strains (38.1%) were detected as clarithromycin resistant (>0.5 mg l ). The new A2115G (:6, 25%), A2144T (:7, 29.1%) and G2141A, 8 (:8, 33.3%) mutations and the classical A2142G (:8, 33.3%) and A2143G (:11, 45.8%) point mutations were detected in the 24 clarithromycin-resistant strains. The A2144T point mutation had the highest median MIC value (3 mg l ) amongst the new mutations, but the classical mutations (A2142G and A2143G) had the highest median MIC values (256 mg l ) overall. The presence of the A2115G (OR:31.66), A2144T (OR:36.92) or G2141A (OR:28.16) mutations increased the likelihood of clarithromycin resistance in strains by 31.66-, 36.92- and 28.16-fold (ORs), respectively, according to the binary logistic regression analysis.

. We concluded that classical mutations of the 23 S rRNA gene resulted in higher clarithromycin MIC values than new mutations. These new point mutations caused moderate elevations in the MIC values of clarithromycin-resistant strains.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000944
2019-04-01
2022-09-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/68/4/566.html?itemId=/content/journal/jmm/10.1099/jmm.0.000944&mimeType=html&fmt=ahah

References

  1. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 2017; 153:420–429 [View Article]
    [Google Scholar]
  2. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127–1131 PMID: 1891020 [View Article]
    [Google Scholar]
  3. Shinzaki S, Fujii T, Bamba S, Ogawa M, Kobayashi T et al. Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease. Intest Res 2018; 16:609–618 [View Article]
    [Google Scholar]
  4. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol 2011; 8:79–88 [View Article]
    [Google Scholar]
  5. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010; 59:1143–1153 [View Article]
    [Google Scholar]
  6. Hultén K, Gibreel A, Sköld O, Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 1997; 41:2550–2553 PMCID: PMC164161 [View Article]
    [Google Scholar]
  7. Ahmad N, Zakaria WR, Abdullah SA, Mohamed R. Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori . World J Gastroenterol 2009; 15:3161 [View Article]
    [Google Scholar]
  8. Toracchio S, Aceto GM, Mariani-Costantini R, Battista P, Marzio L. Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori . Helicobacter 2004; 9:396–399 [View Article]
    [Google Scholar]
  9. De Francesco V, Zullo A, Hassan C, Giorgio F, Rosania R et al. Mechanisms of Helicobacter pylori antibiotic resistance: an updated appraisal. World J Gastrointest Pathophysiol 2011; 2:35–41 [View Article]
    [Google Scholar]
  10. Fontana C, Favaro M, Minelli S, Criscuolo AA, Pietroiusti A et al. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 2002; 46:3765–3769 [View Article]
    [Google Scholar]
  11. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Breakpoint tables for interpretation of MICs and zone diameters (version 6.0); 2013 http://www.eucast.org/clinical_breakpoints/ 6 August, 2018
  12. Tharmalingam N, Port J, Castillo D, Mylonakis E. Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori . Sci Rep 2018; 8:3701 PMID: 29487357 [View Article]
    [Google Scholar]
  13. De Francesco V, Zullo A, Giorgio F, Saracino I, Zaccaro C et al. Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy. J Med Microbiol 2014; 63:453–457 [View Article]
    [Google Scholar]
  14. Ménard A, Santos A, Mégraud F, Oleastro M. PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. Antimicrob Agents Chemother 2002; 46:1156–1157 [View Article]
    [Google Scholar]
  15. Oleastro M, Ménard A, Santos A, Lamouliatte H, Monteiro L et al. Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori . J Clin Microbiol 2003; 41:397–402 [View Article]
    [Google Scholar]
  16. Agudo S, Pérez-Pérez G, Alarcón T, López-Brea M. High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain. J Clin Microbiol 2010; 48:3703–3707 [View Article]
    [Google Scholar]
  17. Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ et al. European Helicobacter and microbiota study group and consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut 2017; 66:6–30
    [Google Scholar]
  18. Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther 2016; 43:514–533 [View Article]
    [Google Scholar]
  19. Georgopoulos SD, Xirouchakis E, Martinez-Gonzalez B, Sgouras DN, Spiliadi C et al. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area. Helicobacter 2013; 18:459–467 [View Article]
    [Google Scholar]
  20. Boyanova L, Mitov I. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev Anti Infect Ther 2010; 8:59–70 [View Article]
    [Google Scholar]
  21. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62:34–42 [View Article]
    [Google Scholar]
  22. Larsen AL, Ragnhildstveit E, Moayeri B, Eliassen L, Melby KK. Resistance rates of metronidazole and other antibacterials in Helicobacter pylori from previously untreated patients in Norway. APMIS 2013; 121:353–358 [View Article]
    [Google Scholar]
  23. Caliskan R, Tokman HB, Erzin Y, Saribas S, Yuksel P et al. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. Rev Soc Bras Med Trop 2015; 48:278–284 [View Article]
    [Google Scholar]
  24. Monno R, Giorgio F, Carmine P, Soleo L, Cinquepalmi V et al. Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study. APMIS 2012; 120:712–717 [View Article]
    [Google Scholar]
  25. De Francesco V, Zullo A, Ierardi E, Vaira D. Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for clarithromycin resistance in Helicobacter pylori . Dig Liver Dis 2009; 41:610–611 [View Article]
    [Google Scholar]
  26. Binyamin D, Pastukh N, On A, Paritsky M, Peretz A. Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones. Gut Pathog 2017; 9:1 [View Article]
    [Google Scholar]
  27. van Doorn LJ, Glupczynski Y, Kusters JG, Megraud F, Midolo P et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001; 45:1500–1504 [View Article]
    [Google Scholar]
  28. Owen RJ. Molecular testing for antibiotic resistance in Helicobacter pylori . Gut 2002; 50:285–289 [View Article]
    [Google Scholar]
  29. Mégraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53:1374–1384 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000944
Loading
/content/journal/jmm/10.1099/jmm.0.000944
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error